Home | Privacy & Terms

  • About RedHill
    • Company Profile
    • Management Team
    • Board of Directors
    • Advisory Board
  • Products
    • Pipeline Overview
    • RHB-101 (Cardio)
    • RHB-102 (Oncology Support)
    • RHB-103 (Migraine)
    • RHB-104 (Crohn's)
    • RHB-104 (MS)
    • RHB-105 (H. pylori)
    • RHB-106 (GI)
  • Partnering
  • Investors
  • News
  • Contact

RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (prevention of nausea and vomiting)

Published on February 13, 2012 in News.

RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (Nausea and Vomiting) Feb 12th 2012

RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (Nausea and Vomiting) Feb 12th 2012 (Hebrew)

Feed for this Entry

News


© All rights reserved for RedHill Biopharma Ltd